S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
S&P 500   4,591.67 (+1.17%)
DOW   35,227.03 (+1.87%)
QQQ   386.20 (+0.80%)
AAPL   165.32 (+2.15%)
MSFT   326.19 (+0.98%)
FB   317.87 (+3.59%)
GOOGL   2,863.10 (+0.81%)
AMZN   3,427.37 (+1.11%)
TSLA   1,009.01 (-0.59%)
NVDA   300.37 (-2.14%)
BABA   123.60 (+10.40%)
NIO   32.34 (+0.59%)
CGC   10.15 (+1.60%)
AMD   139.06 (-3.44%)
GE   96.01 (+3.49%)
MU   82.45 (+1.02%)
T   23.28 (-0.77%)
F   19.22 (+0.42%)
DIS   150.37 (+2.84%)
PFE   51.48 (-5.14%)
AMC   28.79 (-0.76%)
ACB   5.97 (+2.58%)
BA   205.88 (+3.72%)
NYSE:IVC

Invacare Stock Forecast, Price & News

$2.41
0.00 (0.00%)
(As of 12/6/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.18
$2.58
50-Day Range
$2.37
$5.27
52-Week Range
$2.18
$10.94
Volume
1.47 million shs
Average Volume
596,838 shs
Market Capitalization
$84.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.05
30 days | 90 days | 365 days | Advanced Chart
Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.


Invacare logo

About Invacare

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.

Headlines

Invacare Gets Warning Letter From FDA - MarketWatch
December 1, 2021 |  marketwatch.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
46120310
Employees
3,400
Year Founded
1885

Sales & Book Value

Annual Sales
$850.69 million
Cash Flow
$0.32 per share
Book Value
$6.84 per share

Profitability

Net Income
$-28.28 million
Pretax Margin
-5.61%

Debt

Price-To-Earnings

Miscellaneous

Free Float
32,852,000
Market Cap
$84.41 million
Optionable
Optionable

Company Calendar

Last Earnings
10/27/2021
Today
12/06/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/09/2022

Social Links


MarketRank

Overall MarketRank

2.14 out of 5 stars

Medical Sector

468th out of 1,390 stocks

Surgical Appliances & Supplies Industry

10th out of 27 stocks

Analyst Opinion: 3.5Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Invacare (NYSE:IVC) Frequently Asked Questions

Is Invacare a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Invacare stock.
View analyst ratings for Invacare
or view top-rated stocks.

How has Invacare's stock price been impacted by Coronavirus (COVID-19)?

Invacare's stock was trading at $6.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, IVC stock has decreased by 60.2% and is now trading at $2.41.
View which stocks have been most impacted by COVID-19
.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Invacare
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) announced its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.12) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.20) by $0.08. The health services provider had revenue of $224.20 million for the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative trailing twelve-month return on equity of 10.50% and a negative net margin of 6.05%. During the same period in the prior year, the business posted ($0.10) earnings per share.
View Invacare's earnings history
.

What guidance has Invacare issued on next quarter's earnings?

Invacare updated its FY 2021 earnings guidance on Wednesday, November, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $839.92 million-$865.37 million, compared to the consensus revenue estimate of $880.88 million.

What price target have analysts set for IVC?

2 Wall Street analysts have issued twelve-month target prices for Invacare's shares. Their forecasts range from $8.00 to $9.00. On average, they expect Invacare's share price to reach $8.50 in the next year. This suggests a possible upside of 252.7% from the stock's current price.
View analysts' price targets for Invacare
or view top-rated stocks among Wall Street analysts.

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Matthew E. Monaghan, Chairman, President & Chief Executive Officer
  • Kathleen Patricia Leneghan, Senior VP, Chief Financial & Accounting Officer
  • Angie Goodwin, Chief Technology & Information Officer
  • Anthony C. LaPlaca, Secretary, Chief Administrative Officer & SVP
  • Ralf Ledda, Senior VP & General Manager-EMEA Region

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare CEO Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among Invacare's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.09%), Paradigm Capital Management Inc. NY (8.41%), Dimensional Fund Advisors LP (6.09%), Renaissance Technologies LLC (5.66%), Morgan Stanley (4.77%) and Healthcare of Ontario Pension Plan Trust Fund (3.85%). Company insiders that own Invacare stock include Anthony Laplaca and Baiju R Shah.
View institutional ownership trends for Invacare
.

Which institutional investors are selling Invacare stock?

IVC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Deutsche Bank AG, Pura Vida Investments LLC, Dimensional Fund Advisors LP, Morgan Stanley, BlackRock Inc., Two Sigma Investments LP, and Assenagon Asset Management S.A.. Company insiders that have sold Invacare company stock in the last year include Anthony Laplaca, and Baiju R Shah.
View insider buying and selling activity for Invacare
or view top insider-selling stocks.

Which institutional investors are buying Invacare stock?

IVC stock was acquired by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, PEAK6 Investments LLC, Healthcare of Ontario Pension Plan Trust Fund, GSA Capital Partners LLP, Exchange Traded Concepts LLC, Franklin Resources Inc., KBC Group NV, and Marshall Wace LLP.
View insider buying and selling activity for Invacare
or or view top insider-buying stocks.

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $2.41.

How much money does Invacare make?

Invacare has a market capitalization of $84.41 million and generates $850.69 million in revenue each year. The health services provider earns $-28.28 million in net income (profit) each year or ($1.52) on an earnings per share basis.

How many employees does Invacare have?

Invacare employs 3,400 workers across the globe.

When was Invacare founded?

Invacare was founded in 1885.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

Where are Invacare's headquarters?

Invacare is headquartered at ONE INVACARE WAY, ELYRIA OH, 44036.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider can be reached via phone at (440) 329-6000, via email at [email protected], or via fax at 877-619-7996.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.